当前位置:首页 - 行情中心 - 奥翔药业(603229) - 财务分析 - 资产负债表

奥翔药业

(603229)

  

流通市值:60.49亿  总市值:60.49亿
流通股本:5.93亿   总股本:5.93亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金1,022,733,169.661,147,974,656.851,096,813,021.14608,853,480.77
应收票据及应收账款293,556,875.05231,549,025.16172,887,191.64134,812,057.22
其中:应收票据-518,252.333,055,737.5-
应收账款293,556,875.05231,030,772.83169,831,454.14134,812,057.22
预付款项13,752,832.16,253,464.892,112,000.753,816,490.19
其他应收款合计1,444,791.543,719,156.310,798,343.718,489,909.94
存货337,971,124.34326,141,713.33336,187,177.39320,565,103.46
其他流动资产36,611,060.5838,785,239.356,418,629.0856,148,984.47
流动资产平衡项目0000
流动资产合计1,713,131,862.211,761,485,264.771,677,280,912.831,136,705,157.96
非流动资产:
其他非流动金融资产68,142,251.0667,642,251.0667,642,251.0650,142,251.06
固定资产297,815,212.76300,211,169.69262,773,273.93265,934,276.42
在建工程721,373,197.64710,356,586.86717,608,076.52685,009,375.56
无形资产151,316,818.35152,055,979.63153,496,647.13153,949,141.51
递延所得税资产9,162,172.148,682,428.037,237,591.266,868,959.16
其他非流动资产12,348,997.1612,830,141.3516,360,433.9816,721,027.11
非流动资产平衡项目0000
非流动资产合计1,260,158,649.111,251,778,556.621,225,118,273.881,178,625,030.82
资产平衡项目0000
资产总计2,973,290,511.323,013,263,821.392,902,399,186.712,315,330,188.78
流动负债:
短期借款250,279,855.18250,207,077.4250,252,273.63160,120,228.06
应付票据及应付账款440,512,758.57502,438,180.65465,998,966.16519,321,755.56
其中:应付票据158,725,884.24222,698,031.01155,844,770.76149,322,635.18
应付账款281,786,874.33279,740,149.64310,154,195.4369,999,120.38
合同负债15,139,992.0711,410,711.2318,262.4312,628,890.85
应付职工薪酬36,207,459.738,888,231.5119,450,249.2539,776,713.89
应交税费14,349,865.612,751,972.3819,063,233.473,828,905.55
其他应付款合计947,049.53722,545.351,445,436.07580,829.03
一年内到期的非流动负债7,174,208.617,175,215.559,108,915.869,158,959.19
其他流动负债73,048.0364,735.3922,813.277,674.37
流动负债平衡项目0000
流动负债合计764,684,237.29823,658,669.43765,660,150.14745,423,956.5
非流动负债:
长期借款53,367,313.253,368,411.5372,744,479.7572,744,276.83
递延收益29,170,774.8727,968,974.8823,138,174.8923,507,374.9
递延所得税负债13,018,281.4613,018,281.4612,220,872.4912,514,059.91
非流动负债平衡项目0000
非流动负债合计95,556,369.5394,355,667.87108,103,527.13108,765,711.64
负债平衡项目0000
负债合计860,240,606.82918,014,337.3873,763,677.27854,189,668.14
所有者权益(或股东权益):
实收资本(或股本)593,069,389423,620,992423,620,992401,866,704
资本公积677,453,105.82846,901,502.82846,901,502.82394,722,008.9
其他综合收益-824,389.19-929,476.22-943,964.38-907,909.42
盈余公积76,597,029.6876,597,029.6876,597,029.6876,597,029.68
未分配利润766,754,769.19749,059,435.81682,459,949.32588,862,687.48
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计2,113,049,904.52,095,249,484.092,028,635,509.441,461,140,520.64
股东权益平衡项目0000
股东权益合计2,113,049,904.52,095,249,484.092,028,635,509.441,461,140,520.64
负债和股东权益合计2,973,290,511.323,013,263,821.392,902,399,186.712,315,330,188.78
公告日期2023-10-282023-08-302023-04-282023-04-28
审计意见(境内)标准无保留意见
TOP↑